Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Return on Equity (2021 - 2025)

Senti Biosciences has reported Return on Equity over the past 5 years, most recently at 9.9% for Q4 2025.

  • Quarterly results put Return on Equity at 9.9% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 9.9% (changed N/A YoY), and the annual figure for FY2025 was 4.34%, changed.
  • Return on Equity for Q4 2025 was 9.9% at Senti Biosciences, down from 3.01% in the prior quarter.
  • Over the last five years, Return on Equity for SNTI hit a ceiling of 0.43% in Q2 2024 and a floor of 9.9% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.23% (2023), compared with a mean of 1.07%.
  • Biggest five-year swings in Return on Equity: surged 281bps in 2023 and later plummeted -301bps in 2025.
  • Senti Biosciences' Return on Equity stood at 0.23% in 2021, then tumbled by -245bps to 0.33% in 2022, then soared by 150bps to 0.16% in 2023, then crashed by -101bps to 0.0% in 2024, then tumbled by -1062929bps to 9.9% in 2025.
  • The last three reported values for Return on Equity were 9.9% (Q4 2025), 3.01% (Q3 2025), and 1.04% (Q2 2025) per Business Quant data.